Key result
Developing NSTEMI within 28 days of COVID-19 symptoms significantly increased the odds of death within 6 months (OR 33.2; P<0.0001).
Why the study?
Predictors of death within 6 months after non-ST elevation myocardial infarction in patients with a history of COVID-19 were not fully identified.
Does a history of COVID-19 increase the risk of death within 6 months in patients with NSTEMI?
Cohort (n=185)
No
Does a history of COVID-19 increase the risk of death within 6 months in patients with NSTEMI?
Developing NSTEMI within 28 days of a COVID-19 infection is associated with a substantially increased risk of 6-month mortality.
NSTEMI soon after COVID-19 may warrant closer surveillance; leaves open whether infection history should modify post-MI protocols.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Chashchin et al. (2022) conducted a cohort in Non-ST elevation myocardial infarction (NSTEMI) in post-COVID-19 patients (n=185). History of COVID-19 vs. No history of COVID-19 was evaluated on Death within 6 months (p=0.0558). Developing NSTEMI within 28 days of COVID-19 symptoms significantly increased the odds of death within 6 months (OR 33.2; P<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: